Developing patient‐centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population-Reference-Cited by-同舟云学术

Developing patient‐centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population

Published:2020-09-17 Issue:10 Volume:86 Page:2008-2013
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Riet‐Nales Diana A.¹^ORCID,Sundberg Katarina²^ORCID,Boer Anthonius¹^ORCID,Hirschlérova Blanka³

Affiliation:

1. Medicines Evaluation Board, DVRN: International Collaboration Center, ADB: Chair of MEB Utrecht the Netherlands

2. Department of Pharmaceutics and Biotechnology Swedish Medical Products Agency Uppsala Sweden

3. Department of Pharmaceutical Assessment of Chemical and Herbal Products State Institute for Drug Control Prague Czech Republic

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14530

Reference39 articles.

1. Fostering engagement and independence: opportunities and challenges for an aging society;Anderson LA;Health Educ Behav,2014

2. Economic and policy implications of improving longevity;Vladeck BC;J Am Ger Soc,2005

3. The effect of trends in health and longevity on health services use by older adults;Wouterse B;BMC Health Serv Res,2015

4. Ageing in the European Union

5. Design of pharmaceutical products to meet future patient needs requires modification of current development paradigms and business models

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Engagement in Health Policy‐Making for Older Adults: A Systematic Search and Scoping Review;Health Expectations;2024-08

2. Recent developments in pediatric and geriatric dosage forms;Novel Formulations and Future Trends;2024

3. Development of Appropriate Medicines for Older Patients: An Industrial Perspective;Pharmaceutical Formulations for Older Patients;2023

4. Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population;British Journal of Clinical Pharmacology;2022-02-09

5. Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life;British Journal of Clinical Pharmacology;2020-09-17